Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte‐colony stimulating factor) in the treatment of patients with advanced, refractory cancer | Zendy

AI Assistant Blog Pricing

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte‐colony stimulating factor) in the treatment of patients with advanced, refractory cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.